Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis

Abstract Background Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma (HCC), but the results are disputable. Thus, we conducted this meta-analysis to assess the efficacy and safety of the combination tre...

Full description

Bibliographic Details
Main Authors: Rong Cai, Rongfeng Song, Pengfei Pang, Yan Yan, Yifeng Liao, Cuiling Zhou, Shuncong Wang, Xiuling Zhou, Huaping Wang, Hongyu Zhang, Huanhuan Sun, Haiqing Ma
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Transcatheter arterial chemoembolization
TACE
Advanced hepatocellular carcinoma
Sorafenib
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s12885-017-3707-5

Internet

http://link.springer.com/article/10.1186/s12885-017-3707-5

Similar Items